MYL News and Press, Mylan N.V. From 04/01/20

In a note, UBS regards the republished results from one of the first randomized trials evaluating malaria drug hydroxychloroquine (HCQ) in COVID-19 patients as "inconclusive." More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Well...

Pfizer (NYSE: PFE) swam against the current last year. Unfortunately, it was a bad time to do so. While the S&P 500 Index soared nearly 29% higher, Pfizer's shares fell 10%. So far in 2020, Pfizer isn't swimming against the current any longer. Shareholders wish it would. The stock has...

HERTFORDSHIRE, England , PITTSBURGH and MUMBAI, India , March 27, 2020 /PRNewswire/ -- Mylan N.V.  (NASDAQ: MYL) and Lupin Limited (Lupin) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinio...

The COVID-19 pandemic is affecting our social lives, as governmental authorities in most U.S. states have implemented drastic measures -- including social distancing -- to mitigate the spread of the disease. The outbreak also continues to wreak havoc on equity markets. Year to date, the S&P...

The coronavirus pandemic has so far resulted in the shutdown of economies around the globe and driven stocks into a bear market. Biotech and pharmaceutical companies are racing to develop treatments and prevention for COVID-19, the illness caused by the new coronavirus. And at the same time, a s...

Allakos Reports Encouraging Data for Antolimab Allakos (ALLK) announced that it has received positive response from Phase 1 trial of its lead drug candidate antolimab. Phase 1 trial is an open label study designed to evaluate the lead drug candidate in seven patients suffering from moder...

Pfizer 's (NYSE: PFE) plans to merge its huge post-exclusivity segment, Upjohn, with another giant drugmaker,  Mylan (NASDAQ: MYL) hit a coronavirus induced snag. According to Mylan, the plan to create a new company with between $19 billion and $20 billion in combined annual revenue w...

In a note, UBS reports that India's Directorate General of Foreign Trade has instituted a moratorium on the export of hydroxychloroquine, a malaria drug in high demand for the treatment of severely ill COVID-19 patients, although the fulfillment of orders placed before the ban will be allowe...

According to a statement from US President Donald Trump, the US Food and Drug Administration (FDA) will fast-track treatments for novel coronavirus (COVID-19). Though there are still months of research ahead, there are several new developments from drug developers and producers that are giv...

Citing delays associated with the COVID-19 pandemic, Mylan N.V. (NASDAQ: MYL ) and Pfizer (NYSE: PFE ) now expect the merger between Mylan and Upjohn to be finalized in H2 instead of next quarter. More news on: Mylan N.V., Pfizer Inc., Healthcare stocks news, Merger & acquisition new...